Company registration number: 10092598
Annual report and unaudited financial statements
for the year ended 31 March 2026
for
Motus Medical Ltd
Pages for filing with the Registrar
Company registration number: 10092598
Motus Medical Ltd
Balance sheet
as at 31 March 2026
2026 2025
Note £ £ £ £
Fixed assets
Owned:
Tangible assets 4 57,061 69,800
57,061 69,800
Current assets
Debtors 452,287 603,502
Cash at bank and in hand 59,093 83,151
511,380 686,653
Creditors: amounts falling due within one year
(484,442) (541,061)
Net current assets 26,938 145,592
Total assets less current liabilities 83,999 215,392
Creditors: Amounts falling due after more than one year
(69,116) (158,256)
NET ASSETS 14,883 57,136
Capital and reserves
Called up share capital 75 75
Other reserves 149,104 149,104
Profit and loss account (134,296) (92,043)
TOTAL EQUITY 14,883 57,136
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 March 2026.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 10092598
Motus Medical Ltd
Balance sheet - continued
as at 31 March 2026
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
Signed by:
Mr D Griffiths, Director
10 August 2026
2
Motus Medical Ltd
Notes to the financial statements
for the year ended 31 March 2026
1 Company information
Motus Medical Ltd is a private company registered in England and Wales. Its registered number is 10092598. The company is limited by shares. Its registered office is Unit 19, Whitebridge Estate, Stone, ST15 8LQ.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the director has assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company’s ability to continue as a going concern. In making this assessment, the director takes into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The director considers that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is recognised from sales when a performance obligation under a valid contract with a customer has been satisfied at the transaction price allocated to that obligation. Transaction prices so recognised exclude Value Added Tax and any other sales taxes.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
Plant - 18% reducing balance
3 Average number of employees
During the year the average number of employees was 11 (2025 - 11).
3
Motus Medical Ltd
Notes to the financial statements - continued
for the year ended 31 March 2026
4 Tangible fixed assets
Plant and machinery etc.

£
Cost
At 1 April 2025 124,816
At 31 March 2026 124,816
Depreciation
At 1 April 2025 55,016
Charge for year 12,739
At 31 March 2026 67,755
Net book value
At 31 March 2026 57,061
At 31 March 2025 69,800
4